financial post
Aurion Biotech Announces Positive Topline Data for Phase 1/2 Clinical Trial of AURN001, an Allogeneic Cell Therapy Product Candidate for the Treatment of Corneal Edema Secondary to Corneal Endothelial Dysfunction
Financial Post • 4 DAYS AGO
Explorance Announces Appointment of General Manager of Enterprise Solutions & Thought Leadership
Financial Post • 4 DAYS AGO
Redecan Cannabis Launches New Limited-Edition Genetics and Expands Signature ‘Wrapped & Redee’ Pre-roll Line for the Holidays
Financial Post • 4 DAYS AGO
NuVista Energy Ltd. Advises of Impact of Unscheduled Third-Party Downtime
Financial Post • 4 DAYS AGO